| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Group (McEachern Laboratory) and Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
The presence of 10 µM dipyridamole in incubation media of L1210/C2 cells decreased initial rates of zero-trans influx of formycin B (FB, 50 µM), a poorly metabolized inosine analogue, from 4.84 pmol/µl cell water/s to 0.87 pmol/µl cell water/s. However, after a 5-min interval of uptake, free FB levels in dipyridamole-treated cells were 165 pmol/µl cell water, 2.3-fold greater than in dipyridamole-free cultures. This indicated the presence of a concentrative, dipyridamole-insensitive nucleoside transport (NT) system in L1210 cells, in addition to the equilibrative NT systems known to be expressed in these cells. The concentrative system was demonstrable only in the presence of NT inhibitors and required extracellular Na+. The presence of 8 µM 6-[(4-nitrobenzyl)thio]-9-ß-D-ribofuranosylpurine or 15 µM dilazep also induced an accumulation of free FB above steady-state levels, although of a lesser magnitude than that observed with dipyridamole. It appears that NT inhibitors induced nucleoside accumulation by inhibiting bidirectional nucleoside movements mediated by the equilibrative component of nucleoside transport in L1210/C2 cells without interfering with inward FB fluxes mediated by the Na+-dependent transporter. The presence of NT inhibitors also enhanced the cellular accumulation and retention of arabinosyladenine and its 5'-triphosphate in these cells. The increased cellular accumulation of 9-ß-D-arabinofuranosyladenine and 9-ß-D-arabinofuranosyladenine triphosphate by dipyridamole was associated with enhanced antiproliferative activity of 9-ß-D-arabinofuranosyladenine towards the leukemia cells.
1 This study was supported by the National Cancer Institute of Canada.
2 Recipient of a Studentship award from the Alberta Heritage Foundation for Medical Research. Present address: Institut de Recherches Cliniques de Montréal, 110 Avenue des Pins Ouest, Montréal, Québec, Canada H2W 1R7.
3 Senior Research Scientist of the National Cancer Institute of Canada. To whom requests for reprints should be addressed, at Department of Pharmacology, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada.
Received 9/11/87. Accepted 7/12/90.
This article has been cited by other articles:
![]() |
T. T. Lang, M. Selner, J. D. Young, and C. E. Cass Acquisition of Human Concentrative Nucleoside Transporter 2 (hCNT2) Activity by Gene Transfer Confers Sensitivity to Fluoropyrimidine Nucleosides in Drug-Resistant Leukemia Cells Mol. Pharmacol., November 1, 2001; 60(5): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Burke, S. Lee, P. J. Ferguson, and J. R. Hammond Interaction of 2',2'-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1333 - 1340. [Abstract] [Full Text] |
||||
![]() |
S. Y. M. Yao, A. M. L. Ng, W. R. Muzyka, M. Griffiths, C. E. Cass, S. A. Baldwin, and J. D. Young Molecular Cloning and Functional Characterization of Nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) Equilibrative Nucleoside Transporter Proteins (rENT1 and rENT2) from Rat Tissues J. Biol. Chem., November 7, 1997; 272(45): 28423 - 28430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Borgl and a. F. E. Parkinson Uptake and Release of [3H]Formycin B via Sodium-Dependent Nucleoside Transporters in Mouse Leukemic L1210/MA27.1 Cells J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 347 - 353. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |